Incidence of de novo migraine after premenopausal bilateral oophorectomy
Maturitas · 2025
DOI: 10.1016/j.maturitas.2025.108657 ↗Kurz gefasst
Fachartikel in der Zeitschrift Maturitas, 2025. Verfasst von Samantha E Mannion und 6 weiteren Autor:innen. Beteiligte Einrichtung: Women's Health Research Center, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, United States; Division of General Internal Medicine, Northwes…. Hauptthemen laut MEDLINE: Ovariectomy, Premenopause, Migraine Disorders, Estrogen Replacement Therapy. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIA NIH HHS, Foundation for the National Institutes of Health, National Institutes of Health.
Abstract (Originalsprache)
OBJECTIVE: Little is known about the effects of premenopausal bilateral oophorectomy on the development of migraine. We compared migraine outcomes for women undergoing oophorectomy with those of referent women. STUDY DESIGN: The cohort included 1243 women who underwent premenopausal bilateral oophorectomy in Olmsted County, MN, US between 1988 and 2007 and 1415 age-matched (±1 year) referent women. Women diagnosed with migraine before oophorectomy (or index) were excluded. Estrogen therapy after oophorectomy was assessed as a time-dependent factor. RESULTS: Women who underwent oophorectomy had an increased risk of de novo migraine compared with referent women (HR, 1.59; 95 % CI, 1.24-2.05). The risk was particularly higher for women who underwent oophorectomy under the age of 45 years. An increased risk of migraine without aura, but not of migraine with aura, was observed, as is characteristic of menstrual migraines. The risk of de novo migraine in the women with oophorectomy off estrogen was comparable to that of the referent women (HR, 0.80; 95 % CI, 0.43-1.52). By contrast, women with oophorectomy on estrogen had an increased risk of migraine (HR, 2.08; 95 % CI, 1.47-2.92). CONCLUSIONS: Premenopausal bilateral oophorectomy is associated with an increased risk of migraine. Although estrogen is known to mitigate the severity of menopause-related symptoms, the higher risk for migraine among women using estrogen could be the result of them being prescribed estrogen because of greater severity of menopause symptoms. We encourage future studies to examine how the type, dose, and route of estrogen impact migraine outcomes after oophorectomy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Women's Health Research Center, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, United States; Division of General Internal Medicine, Northwestern University, 420 E Superior St, Chicago, IL 60611, United States.…
- Division of Clinical Trials and Biostatistics, Department of Quantitative Health Sciences, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, United States. Electronic address: Smith.Carin@mayo.edu.
- Women's Health Research Center, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, United States; Division of General Internal Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, United States. Electron…
- Division of Epidemiology, Department of Quantitative Health Sciences, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, United States.
- Division of Epidemiology, Department of Quantitative Health Sciences, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, United States. Electronic address: StSauver.Jennifer@mayo.edu.
- Women's Health Research Center, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, United States; Division of Epidemiology, Department of Quantitative Health Sciences, Mayo Clinic, 200 First Street SW, Rochester, MN…
Förderung
- NIA NIH HHS
- Foundation for the National Institutes of Health
- National Institutes of Health
- Mayo Clinic
- National Institute on Aging
Zitieren
APA
Mannion, S. E., Smith, C. Y., Buzzard, J. A., Gazzuola Rocca, L., St Sauver, J., Rocca, W. A., & Kapoor, E. (2025). Incidence of de novo migraine after premenopausal bilateral oophorectomy. Maturitas. https://doi.org/10.1016/j.maturitas.2025.108657
Vancouver
Mannion SE, Smith CY, Buzzard JA, Gazzuola Rocca L, St Sauver J, Rocca WA, et al. Incidence of de novo migraine after premenopausal bilateral oophorectomy. Maturitas. 2025. doi:10.1016/j.maturitas.2025.108657
BibTeX
@article{Mannion2025,
author = {Mannion, Samantha E and Smith, Carin Y and Buzzard, Jennifer A and Gazzuola Rocca, Liliana and St Sauver, Jennifer and Rocca, Walter A and Kapoor, Ekta},
title = {Incidence of de novo migraine after premenopausal bilateral oophorectomy},
journal = {Maturitas},
year = {2025},
doi = {10.1016/j.maturitas.2025.108657}
}
EUVIMED